{"count": 9, "results": [{"_id": "33268288", "pmid": 33268288, "title": "Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy.", "journal": "Curr Res Transl Med", "authors": ["Zhao Q", "Song W", "Huang J", "Wang D", "Xu C"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.retram.2020.103270", "meta_date_publication": "2021 Jan", "meta_volume": "69", "meta_issue": "1", "meta_pages": "103270", "score": 50269.273, "text_hl": "However, whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@HHcy@@@-induced @DISEASE_Cardiomegaly @DISEASE_MESH:D006332 @@@cardiac hypertrophy@@@ is unclear. ", "citations": {"NLM": "Zhao Q, Song W, Huang J, Wang D, Xu C. Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy. Curr Res Transl Med. 2021 Jan;69(1):103270. PMID: 33268288", "BibTeX": "@article{33268288, title={Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy.}, author={Zhao Q and Song W and Huang J and Wang D and Xu C}, journal={Curr Res Transl Med}, volume={69}, number={1}, pages={103270}}"}}, {"_id": "31678650", "pmid": 31678650, "title": "Metformin inhibited homocysteine-induced upregulation of endothelin receptors through the Sirt1/NF-kappaB signaling pathway in vascular smooth muscle cells.", "journal": "Vascul Pharmacol", "authors": ["Chen Y", "Su X", "Qin Q", "Yu Y", "Jia M", "Kong L", "Zhang H", "Li H"], "date": "2020-01-01T00:00:00Z", "doi": "10.1016/j.vph.2019.106613", "meta_date_publication": "2020 Jan", "meta_volume": "124", "meta_issue": "", "meta_pages": "106613", "score": 50260.918, "text_hl": "In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ significantly inhibited the @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@HHcy@@@-induced blood pressure elevation. ", "citations": {"NLM": "Chen Y, Su X, Qin Q, Yu Y, Jia M, Kong L, Zhang H, Li H. Metformin inhibited homocysteine-induced upregulation of endothelin receptors through the Sirt1/NF-kappaB signaling pathway in vascular smooth muscle cells. Vascul Pharmacol. 2020 Jan;124():106613. PMID: 31678650", "BibTeX": "@article{31678650, title={Metformin inhibited homocysteine-induced upregulation of endothelin receptors through the Sirt1/NF-kappaB signaling pathway in vascular smooth muscle cells.}, author={Chen Y and Su X and Qin Q and Yu Y and Jia M and Kong L and Zhang H and Li H}, journal={Vascul Pharmacol}, volume={124}, pages={106613}}"}}, {"_id": "32448786", "pmid": 32448786, "pmcid": "PMC7252966", "title": "Association of vitamin B12 deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan", "journal": "BMJ Open Diabetes Res Care", "authors": ["Miyan Z", "Waris N", "MIBD"], "date": "2020-05-01T00:00:00Z", "doi": "10.1136/bmjdrc-2019-001151", "meta_date_publication": "2020 May", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50255.816, "text_hl": "Subjects with @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@B12 deficiency@@@ and insufficiency with @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@ (>=15) were found in 19 (76%) micromol/L and 69 (60.5%) micromol/L in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users compared with 6 (100%) micromol/L and 57 (73.1%) mumol/L in non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users, respectively. ", "citations": {"NLM": "Miyan Z, Waris N, MIBD. Association of vitamin B12 deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan BMJ Open Diabetes Res Care. 2020 May;8(1):. PMID: 32448786", "BibTeX": "@article{32448786, title={Association of vitamin B12 deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan}, author={Miyan Z and Waris N and MIBD}, journal={BMJ Open Diabetes Res Care}, volume={8}, number={1}}"}}, {"_id": "37266747", "pmid": 37266747, "title": "Metformin role in Parkinson's disease: a double-sword effect.", "journal": "Mol Cell Biochem", "authors": ["Alrouji M", "Al-Kuraishy HM", "Al-Gareeb AI", "Ashour NA", "Jabir MS", "Negm WA", "Batiha GE"], "date": "2023-06-02T00:00:00Z", "doi": "10.1007/s11010-023-04771-7", "meta_date_publication": "2023 Jun 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50253.72, "text_hl": "However, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may harm @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD neuropathology@@@ by inducing @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@ and @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@deficiency of folate and B12@@@. ", "citations": {"NLM": "Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Ashour NA, Jabir MS, Negm WA, Batiha GE. Metformin role in Parkinson's disease: a double-sword effect. Mol Cell Biochem. 2023 Jun 2;():. PMID: 37266747", "BibTeX": "@article{37266747, title={Metformin role in Parkinson's disease: a double-sword effect.}, author={Alrouji M and Al-Kuraishy HM and Al-Gareeb AI and Ashour NA and Jabir MS and Negm WA and Batiha GE}, journal={Mol Cell Biochem}}"}}, {"_id": "39502352", "pmid": 39502352, "title": "Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment.", "journal": "Int J Angiol", "authors": ["Prasad K"], "date": "2024-07-08T00:00:00Z", "doi": "10.1055/s-0044-1788280", "meta_date_publication": "2024 Dec", "meta_volume": "33", "meta_issue": "4", "meta_pages": "262-270", "score": 50246.91, "text_hl": "...@<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@Hyperhomocysteinemia@@@ (@<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@HHcy@@@) is an independent risk factor for @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@. ", "citations": {"NLM": "Prasad K. Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment. Int J Angiol. 2024 Dec;33(4):262-270. PMID: 39502352", "BibTeX": "@article{39502352, title={Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment.}, author={Prasad K}, journal={Int J Angiol}, volume={33}, number={4}, pages={262-270}}"}}, {"_id": "40737654", "pmid": 40737654, "title": "SERUM VITAMIN B12, FOLIC ACID, HOMOCYSTEINE, AND GLYCEMIC CONTROL MARKERS IN PATIENTS WITH TYPE 2 DIABETES BY METFORMIN AND OTHER ORAL ANTIDIABETIC MEDICATIONS.", "journal": "Georgian Med News", "authors": ["Al-Samydai A", "Oraibi A", "Altamimi S", "Al-Hussaniy H", "Zainee H", "Kareem L", "Abdulhuseen S", "Alghnaimawi F", "Al-Saeedi A", "Hamed H", "Adnan M"], "date": "2025-05-01T00:00:00Z", "meta_date_publication": "2025 May", "meta_volume": "", "meta_issue": "362", "meta_pages": "92-97", "score": 50243.19, "text_hl": "BACKGROUND: @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) is a prevalent @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic disorder@@@ associated with long-term complications. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, the first-line therapy for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, has been implicated in @DISEASE_Malabsorption_Syndromes @DISEASE_MESH:D008286 @@@nutrient malabsorption@@@, particularly @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@vitamin B12@@@, potentially leading to @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@ and related @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic dysfunction@@@. ", "citations": {"NLM": "Al-Samydai A, Oraibi A, Altamimi S, Al-Hussaniy H, Zainee H, Kareem L, Abdulhuseen S, Alghnaimawi F, Al-Saeedi A, Hamed H, Adnan M. SERUM VITAMIN B12, FOLIC ACID, HOMOCYSTEINE, AND GLYCEMIC CONTROL MARKERS IN PATIENTS WITH TYPE 2 DIABETES BY METFORMIN AND OTHER ORAL ANTIDIABETIC MEDICATIONS. Georgian Med News. 2025 May;(362):92-97. PMID: 40737654", "BibTeX": "@article{40737654, title={SERUM VITAMIN B12, FOLIC ACID, HOMOCYSTEINE, AND GLYCEMIC CONTROL MARKERS IN PATIENTS WITH TYPE 2 DIABETES BY METFORMIN AND OTHER ORAL ANTIDIABETIC MEDICATIONS.}, author={Al-Samydai A and Oraibi A and Altamimi S and Al-Hussaniy H and Zainee H and Kareem L and Abdulhuseen S and Alghnaimawi F and Al-Saeedi A and Hamed H and Adnan M}, journal={Georgian Med News}, number={362}, pages={92-97}}"}}, {"_id": "24018893", "pmid": 24018893, "title": "Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.", "journal": "Endocr J", "authors": ["Sato Y", "Ouchi K", "Funase Y", "Yamauchi K", "Aizawa T"], "date": "2013-01-01T00:00:00Z", "doi": "10.1507/endocrj.ej13-0332", "meta_date_publication": "2013", "meta_volume": "60", "meta_issue": "12", "meta_pages": "1275-80", "score": 50061.723, "text_hl": "Relationship between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@vitamin B12 deficiency@@@, @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@ and @DISEASE_Diabetic_Angiopathies @DISEASE_MESH:D003925 @@@vascular complications@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr J. 2013;60(12):1275-80. PMID: 24018893", "BibTeX": "@article{24018893, title={Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.}, author={Sato Y and Ouchi K and Funase Y and Yamauchi K and Aizawa T}, journal={Endocr J}, volume={60}, number={12}, pages={1275-80}}"}}, {"_id": "17908667", "pmid": 17908667, "title": "Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient.", "journal": "J Formos Med Assoc", "authors": ["Lin HY", "Chung CY", "Chang CS", "Wang ML", "Lin JS", "Shen MC"], "date": "2007-09-01T00:00:00Z", "doi": "10.1016/S0929-6646(08)60039-X", "meta_date_publication": "2007 Sep", "meta_volume": "106", "meta_issue": "9", "meta_pages": "774-8", "score": 50060.66, "text_hl": "@DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@Vitamin B12 deficiency@@@ may be induced by long-term use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, which may in turn lead to @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@. ", "citations": {"NLM": "Lin HY, Chung CY, Chang CS, Wang ML, Lin JS, Shen MC. Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient. J Formos Med Assoc. 2007 Sep;106(9):774-8. PMID: 17908667", "BibTeX": "@article{17908667, title={Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient.}, author={Lin HY and Chung CY and Chang CS and Wang ML and Lin JS and Shen MC}, journal={J Formos Med Assoc}, volume={106}, number={9}, pages={774-8}}"}}, {"_id": "11434188", "pmid": 11434188, "title": "Homocysteine and cardiovascular risk in patients with diabetes mellitus.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Yeromenko Y", "Lavie L", "Levy Y"], "date": "2001-04-01T00:00:00Z", "meta_date_publication": "2001 Apr", "meta_volume": "11", "meta_issue": "2", "meta_pages": "108-16", "score": 50045.38, "text_hl": "Some studies show higher than normal fasting and postmethionine load levels of plasma @CHEMICAL_Homocysteine @CHEMICAL_MESH:D006710 @@@homocysteine@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ @SPECIES_9606 @@@patients@@@, particularly in those with @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@ and microalbuminutia. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use and low plasma B vitamins are other potential mechanisms resulting in @<m>DISEASE_Hyperhomocysteinemia</m> @DISEASE_MESH:D020138 @@@hyperhomocysteinemia@@@ in these @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Yeromenko Y, Lavie L, Levy Y. Homocysteine and cardiovascular risk in patients with diabetes mellitus. Nutr Metab Cardiovasc Dis. 2001 Apr;11(2):108-16. PMID: 11434188", "BibTeX": "@article{11434188, title={Homocysteine and cardiovascular risk in patients with diabetes mellitus.}, author={Yeromenko Y and Lavie L and Levy Y}, journal={Nutr Metab Cardiovasc Dis}, volume={11}, number={2}, pages={108-16}}"}}]}